Ten of 11 children born with a rare form of congenital hearing loss experienced improvements after receiving the company’s ...

Fuse Vectors has raised $5.2 million of funding as it moves closer to commercialising its innovative new approach to ...

CompareNetworks is proud to announce the publication of the first issue of Cell & Gene Therapy Review, marking a significant ...

Four children born with a rare genetic form of severe blindness have all experienced significant improvements in their ...

The funding will accelerate the development of Fuse's technology platform and pipeline of novel gene therapies. With its ...

A gene therapy from Regeneron Pharmaceuticals Inc. improved hearing in nearly all deaf children in a clinical trial, results ...

Regeneron Pharmaceuticals said on Monday its experimental gene therapy showed improved hearing in 10 of 11 children between ...

Revolutionary gene therapy approaches show promise in treating various retinal conditions, potentially transforming treatment ...

OTO, is one of several early-stage gene therapies being developed to treat relatively straight-forward causes of genetic ...

Sensorion's Audiogene Phase I/II trial of the SENS-501 gene therapy programme has received a favourable recommendation from ...

Hyderabad: Cell and gene therapy solutions provider Miltenyi Biotec on Monday announced the roll-out of what is touted as ...

Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. | ...